Anika Therapeutics | ANIK - 应收帐款人





应收帐款人 更改 日
Abbott USD 10.57B 171M 2025-12
Agenus USD 22.44M 1.14M 2025-12
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Insmed USD 140.86M 75.6M 2025-12
Integra LifeSciences USD 278.85M 16.69M 2025-12
Intrexon USD 1.02M 559K 2024-06
J&J USD 21.33B 3.72B 2025-12
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
MacroGenics USD 13.37M 55.86M 2025-12
Merit Medical Systems USD 227M 3.39M 2026-03
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 482M 85M 2026-03
Smith & Nephew USD 1.48B 85M 2025-12
Stryker USD 3.57B 468M 2026-03
Surmodics USD 23.56M 288K 2025-06
Veracyte USD 44.66M 3.17M 2025-12
Xencor USD 29.3M 7.49M 2025-12
Zimmer Biomet Holdings USD 1.73B 24.2M 2026-03